These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies. Ragnhammar P; Frödin JE; Trotta PP; Mellstedt H Cancer Immunol Immunother; 1994 Oct; 39(4):254-62. PubMed ID: 7525059 [TBL] [Abstract][Full Text] [Related]
31. Effects of continuous localized infusion of granulocyte-macrophage colony-stimulating factor and inoculations of irradiated glioma cells on tumor regression. Wallenfriedman MA; Conrad JA; DelaBarre L; Graupman PC; Lee G; Garwood M; Gregerson DS; Jean WC; Hall WA; Low WC J Neurosurg; 1999 Jun; 90(6):1064-71. PubMed ID: 10350253 [TBL] [Abstract][Full Text] [Related]
32. Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways. Uemura Y; Kobayashi M; Nakata H; Kubota T; Bandobashi K; Saito T; Taguchi H Int J Mol Med; 2006 Aug; 18(2):365-73. PubMed ID: 16820947 [TBL] [Abstract][Full Text] [Related]
33. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Fu YX; Watson G; Jimenez JJ; Wang Y; Lopez DM Cancer Res; 1990 Jan; 50(2):227-34. PubMed ID: 2136804 [TBL] [Abstract][Full Text] [Related]